Biochemical mechanism of kanamycin resistance in Mycobacterium tuberculosis. 1977

S Mitsuhashi, and T Tanaka, and H Kawabe, and H Umezawa

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D002474 Cell-Free System A fractionated cell extract that maintains a biological function. A subcellular fraction isolated by ultracentrifugation or other separation techniques must first be isolated so that a process can be studied free from all of the complex side reactions that occur in a cell. The cell-free system is therefore widely used in cell biology. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p166) Cellfree System,Cell Free System,Cell-Free Systems,Cellfree Systems,System, Cell-Free,System, Cellfree,Systems, Cell-Free,Systems, Cellfree
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000085 Acetates Derivatives of ACETIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxymethane structure. Acetate,Acetic Acid Esters,Acetic Acids,Acids, Acetic,Esters, Acetic Acid
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

S Mitsuhashi, and T Tanaka, and H Kawabe, and H Umezawa
May 1998, Antimicrobial agents and chemotherapy,
S Mitsuhashi, and T Tanaka, and H Kawabe, and H Umezawa
January 1960, The Journal of antibiotics,
S Mitsuhashi, and T Tanaka, and H Kawabe, and H Umezawa
November 2013, Journal of microbiology and biotechnology,
S Mitsuhashi, and T Tanaka, and H Kawabe, and H Umezawa
June 1971, Rinsho byori. The Japanese journal of clinical pathology,
S Mitsuhashi, and T Tanaka, and H Kawabe, and H Umezawa
April 1970, Antibiotiki,
S Mitsuhashi, and T Tanaka, and H Kawabe, and H Umezawa
June 2016, ACS chemical biology,
S Mitsuhashi, and T Tanaka, and H Kawabe, and H Umezawa
September 2003, Antimicrobial agents and chemotherapy,
S Mitsuhashi, and T Tanaka, and H Kawabe, and H Umezawa
October 1967, Kekkaku : [Tuberculosis],
S Mitsuhashi, and T Tanaka, and H Kawabe, and H Umezawa
June 2009, Indian journal of experimental biology,
Copied contents to your clipboard!